Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Farland

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 12, 2018
Acute Thrombotic Microangiopathy and Cortical Necrosis Following Administration of Alemtuzumab: A Case ReportAshley A Liou, Brent M Skiver, Eric Yates, et al.
Frontiers in Bioengineering and Biotechnology|March 18, 2021
Effects of Shear Stress on Production of FVIII and vWF in a Cell-Based Therapeutic for Hemophilia ABrady Trevisan, Alshaimaa Morsi, Julio Aleman, et al.
Pain Medicine (Malden, Mass.)|March 10, 2021
Implementation of Individualized Pain Care Plans Decreases Length of Stay and Hospital Admission Rates for High Utilizing Adults with Sickle Cell DiseaseJena L Welch-Coltrane, Anthony A Wachnik, Meredith C B Adams, et al.
Blood|July 7, 2022
Race, rituximab, and relapse in TTPShruti Chaturvedi, Ana G Antun, Andrew M Farland, et al.
Blood Advances|December 3, 2024
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab eraAyotola Fatola, Michael D Evans, Jenna Brown, et al.
Research and Practice in Thrombosis and Haemostasis|April 23, 2024
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpuraMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 12, 2018
Acute Thrombotic Microangiopathy and Cortical Necrosis Following Administration of Alemtuzumab: A Case ReportAshley A Liou, Brent M Skiver, Eric Yates, et al.
Frontiers in Bioengineering and Biotechnology|March 18, 2021
Effects of Shear Stress on Production of FVIII and vWF in a Cell-Based Therapeutic for Hemophilia ABrady Trevisan, Alshaimaa Morsi, Julio Aleman, et al.
Pain Medicine (Malden, Mass.)|March 10, 2021
Implementation of Individualized Pain Care Plans Decreases Length of Stay and Hospital Admission Rates for High Utilizing Adults with Sickle Cell DiseaseJena L Welch-Coltrane, Anthony A Wachnik, Meredith C B Adams, et al.
Blood|July 7, 2022
Race, rituximab, and relapse in TTPShruti Chaturvedi, Ana G Antun, Andrew M Farland, et al.
Blood Advances|December 3, 2024
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab eraAyotola Fatola, Michael D Evans, Jenna Brown, et al.
Research and Practice in Thrombosis and Haemostasis|April 23, 2024
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpuraMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Pageof 1